Clinical Research and Trial Centre, Lund University Hospital
Lund, SE-221 85, Sweden
NCT Number: NCT00802750
The purpose of this study is to evaluate healthy volunteers perception of catheterization with LoFric catheters with new solvents in the manufacturing process. The subjects will be catheterized three times during one visit day.
The hypothesis is that the subjects' perception of catheterization is the same when using the test catheters compared to the reference catheter.
Looking for future studies?
Notify Me18 year and older
Male
Interventional
Not applicable
Lund, SE-221 85, Sweden
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
LoFric POBE, Nelaton 40 cm, CH 12 with new solvent. Each subject will use the reference catheter "LoFric POBE, Nelaton 40 cm, CH 12 with current solvent" before being catheterized with the test catheters.
Time frame: At each catheterization (three times during one day)
Wellspect HealthCare
Industry
A Randomized, Single-blind, Cross-over, Single Centre Study in Healthy Volunteers Evaluating Subject Perception of Urinary Catheters Manufactured in a New Process With New Solvent
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06851585
Catheterization, Catheterization, Peripheral
Poitiers, France
View Trial DetailsNCT00516906
Catheterization
View Trial DetailsNCT04865783
Anesthetics, Intravenous, Catheterization
Aabenraa, Denmark
View Trial DetailsNCT06271499
Cannulation, Catheterization
Ankara, Turkey (Türkiye)
View Trial Details